Tweet
Below are some excerpts from a recent article we came across. It touches on the negligence that takes place within both the drug companies and the FDA.
An FDA inspection report found an infants' and children's line of Tylenol products to be contaminated with dangerous bacteria (they did not disclose the actual type) as well as "foreign materials" that were visible as "dark or black specks". But a recent story published by USA Today has revealed that McNeil (McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson) actually knew about the bacterial contamination and kept shipping the products anyway.
Only the drug industry could get away with this type of careless, reckless behavior with nothing more than a slap on the wrist from the FDA. In fact, the FDA did not even require McNeil to issue a recall after discovering the problem; McNeil did so voluntarily over "theoretical concerns" that were expressed by Deborah Autor, an FDA official who was quick to emphasize that the risk to consumers from the tainted products "is remote".
Can you imagine what would happen if an herbal product manufacturer were found to engage in the same behavior? The FDA would pounce on them, seize their products, issue a public warning and probably fine the company for its reckless behavior.
The FDA report specifies that McNeil's had not been properly formulating the drug dosages in its children's and infants' medicines, which is part of the reason for the recall. Improper concentrations of active ingredients in these products potentially puts millions of children at risk. But apparently this is no big deal to the FDA which sees it as nothing more than a "hypothetical" problem.
According to a recent Los Angeles Times article, the FDA has not even decided what corrective action it is going to take. According to the story, "options range from sending a warning letter to seeking criminal penalties."
Never mind that a warning letter had already been sent to a McNeil plant in Puerto Rico several months ago over wooden shipping pallet chemicals that had been found in other McNeil drugs, causing 70 people to became ill with digestive problems. When it comes to regulating drug companies, the FDA has a very short memory.
This is just one of the thousands of examples that show us that putting our well-being in the hands of these companies and organizations is dangerous.
You have the power to cut short the reliance that people have on them. We need to stop feeding the system that allows these kind of things to happen.
PATHS offers healthy alternatives to what the drug companies push.
If you know someone who relies on risky medications, have them take a look and see if PATHS offers something to help them.
Thank you for being part of the Revolution to take back our health and well-being.
Article excerpts from NaturalNews.com.
An FDA inspection report found an infants' and children's line of Tylenol products to be contaminated with dangerous bacteria (they did not disclose the actual type) as well as "foreign materials" that were visible as "dark or black specks". But a recent story published by USA Today has revealed that McNeil (McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson) actually knew about the bacterial contamination and kept shipping the products anyway.
Only the drug industry could get away with this type of careless, reckless behavior with nothing more than a slap on the wrist from the FDA. In fact, the FDA did not even require McNeil to issue a recall after discovering the problem; McNeil did so voluntarily over "theoretical concerns" that were expressed by Deborah Autor, an FDA official who was quick to emphasize that the risk to consumers from the tainted products "is remote".
Can you imagine what would happen if an herbal product manufacturer were found to engage in the same behavior? The FDA would pounce on them, seize their products, issue a public warning and probably fine the company for its reckless behavior.
The FDA report specifies that McNeil's had not been properly formulating the drug dosages in its children's and infants' medicines, which is part of the reason for the recall. Improper concentrations of active ingredients in these products potentially puts millions of children at risk. But apparently this is no big deal to the FDA which sees it as nothing more than a "hypothetical" problem.
According to a recent Los Angeles Times article, the FDA has not even decided what corrective action it is going to take. According to the story, "options range from sending a warning letter to seeking criminal penalties."
Never mind that a warning letter had already been sent to a McNeil plant in Puerto Rico several months ago over wooden shipping pallet chemicals that had been found in other McNeil drugs, causing 70 people to became ill with digestive problems. When it comes to regulating drug companies, the FDA has a very short memory.
This is just one of the thousands of examples that show us that putting our well-being in the hands of these companies and organizations is dangerous.
You have the power to cut short the reliance that people have on them. We need to stop feeding the system that allows these kind of things to happen.
PATHS offers healthy alternatives to what the drug companies push.
If you know someone who relies on risky medications, have them take a look and see if PATHS offers something to help them.
Thank you for being part of the Revolution to take back our health and well-being.
Article excerpts from NaturalNews.com.